Concepedia

Author

Motohiro Tamiya

Osaka International Cancer InstituteORCID

Also Known As

M. Tamiya, MOTOHIRO TAMIYA, Motohiro Tamiya, Tamiya, M., Tamiya, Motohiro, Thatthan Suksombooncharoen, Toshihiko Kaneda, Yuichi Tambo

369

Publications

3.5K

Citations

32

H-Index

49

Concepts

All Affiliations

Osaka International Cancer InstituteOsaka Prefectural Medical CenterNHO Kinki Chuo Chest Medical CenterNational Hospital OrganizationToneyama National Hospital
MT

About

Motohiro Tamiya is an author at Osaka International Cancer Institute specializing in medicine, lung cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

34

980

2

Immunology

6

6

163

3

Health Sciences

2

2

66

4

Allergy

1

1

24

5

Molecular Biology

1

1

10

Motohiro Tamiya

×

89

Publications

2.8K

Citations

30

H-Index

YearCitations

Pretreatment advanced lung cancer inflammation index (<scp>ALI</scp>) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

Takayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya,

Cancer Medicine

2017

121

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

Motohiro Tamiya, Akihiro Tamiya, Takako Inoue,

PLoS ONE

2018

105

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim,

Journal of Clinical Oncology

2024

94

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study

Akihiro Tamiya, Motohiro Tamiya, Takashi Nishihara,

Anticancer Research

2017

89

Clinical Evaluation of Endoscopic Bronchial Occlusion with Silicone Spigots for the Management of Persistent Pulmonary Air Leaks

Shinji Sasada, Kazuyo Tamura, Ya-shu Chang,

Internal Medicine

2011

84

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya,

European Journal of Cancer

2021

81

Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial

Kohei Otsubo, Junji Kishimoto, Masahiko Ando,

European Respiratory Journal

2022

81

Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under <scp>L</scp>ung<scp>P</scp>oint guidance for small peripheral pulmonary lesions

Motohiro Tamiya, Norio Okamoto, Shinji Sasada,

Respirology

2013

78

Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib

Kei Kunimasa, Risa Kamada, Toru Oka,

JACC CardioOncology

2020

78

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Shinya Sakata, Kohei Otsubo, Hisako Yoshida,

Cancer Science

2021

68

Page 1